An overweight 55-year-old female visits the ambulatory care clinic for a scheduled blood pressure check. Two weeks ago, she was diagnosed with primary hypertension and prescribed daily oral losartan. Her baseline serum creatinine was and serum potassium was . Today, she feels well and denies any dizziness, headache, or edema. Her blood pressure is . Repeat laboratory testing shows a serum creatinine of and a serum potassium of . Which of the following are the most appropriate next steps in monitoring and treatment evaluation? (Select two)
- Continue the current dose of losartanCevap
- Schedule a routine clinical follow-up in 4 weeksCevap
- CDiscontinue the losartan and switch to a calcium channel blocker
- DOrder a renal artery duplex ultrasound
- EAdd spironolactone to optimize blood pressure control
Cevap
Continue the current dose of losartan AND schedule a routine clinical follow-up in 4 weeks.
Angiotensin II receptor blockers (ARBs) such as losartan exert their antihypertensive effect partly by dilating the efferent arteriole in the kidney. This decreases intraglomerular pressure, which commonly leads to a benign, expected rise in serum creatinine of up to 30% from baseline. In this patient, the creatinine increased from to , an increase of approximately 22%, which is well within the acceptable physiologic threshold. Furthermore, her serum potassium remains safely within normal limits (), and her blood pressure has reached an excellent therapeutic target (). Therefore, the most appropriate management is to continue the current effective medication regimen without any dose adjustments and schedule a routine follow-up appointment in approximately 4 weeks to ensure continued stability.
Adım Adım Çözüm
Anahtar Kavram
Expected physiologic laboratory changes during ACE inhibitor or ARB initiation.